Trends in Molecular Medicine
ReviewFeature ReviewLearning from Jekyll to control Hyde: Hedgehog signaling in development and cancer
Section snippets
Hedgehog (Hh) signaling in cancer
The orderly process of development depends upon well-orchestrated signals. These signals transform a single cell into a complex multicellular organism. Incredibly, in spite of the complex end result, the transformation employs relatively few types of signals, including Wnt, Notch, transforming growth factor-β, fibroblast growth factor and Hedgehog (Hh). These secreted protein signals direct cell proliferation, cell fate determination, epithelial-to-mesenchymal transitions and the rearrangement
Category 1 cancers: Hh signaling is important for tumor initiation and maintenance
Gorlin syndrome is caused by the loss of one functional copy of PTCH[7], which activates the Hh signaling pathway. Several mouse models of Hh pathway activation were engineered and studies in these mice have revealed that constitutive Hh signaling alone is sufficient to form BCC, RMS and MB. Activating the Hh pathway at any of several levels of the signal transduction cascade including SMOH, SUFU and GLI or in conjunction with inactivation of additional tumor-suppressor genes leads to the
Category 2 cancers: Hh signaling is important for maintenance but not initiation of the tumor
In category 2 cancers, Hh signaling does not play a role in tumor initiation but instead is important for tumor maintenance and growth. Examples of category 2 tumors include colon cancer and pancreatic cancer. In both, Hh signals derived from the stroma are important for maintaining proliferation of tumor cells.
Category 3 “unclassified” cancers: Hh signaling is implicated in tumorigenesis but its role is not defined
Category 3 cancers include those where the Hh pathway is active but its role in the initiation and growth of the tumor is not well defined. Many cancers fall into this category and include lymphoma, breast cancer, ovarian cancer, esophageal cancer, liver cancer and lung cancer. We include prostate cancer in this category owing to residual controversy in the field; however, data from Wade Bushman's laboratory as well as multiple mouse models presented in abstract form and at meetings demonstrate
Concluding remarks
In the same way that developmental biology has been unified by near-universal molecules, genes and signaling pathways, cancer biology has been refined by the recognition of changes in signaling pathways including Hh that give tumor cells the properties they require to grow. Hh signaling is sufficient to trigger cancer in cells where Hh signaling is normally necessary for growth and development. Presumably cells that comprise mature tissues, which relied upon Hh signaling for development,
Declaration regarding conflict of interest
No research in the authors’ laboratory or authors’ consulting work is supported by companies that are developing Hh pathway drugs. In the past M.P.S. has served as an expert witness for Genentech on non-Hh pathway topics and E.W.H. has a family member who works at Genentech on projects unrelated to Hh signaling.
References (115)
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
Cell
(1996)The human hair cycle
J. Invest. Dermatol.
(1959)Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway
Dev. Cell
(2006)Epithelial morphogenesis and intestinal cancer: new insights in signaling mechanisms
Adv. Cancer Res.
(2008)- et al.
Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog
Neuron
(1999) Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/−)p53(−/−) mice
Cancer Cell
(2004)Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure
Cancer Cell
(2008)Genetic and epigenetic control of skeletal muscle development
Ann. Anat.
(2005)- et al.
Expression of hedgehog pathway components in the adult colon
Gastroenterology
(2006) - et al.
The morphogenetic code and colon cancer development
Cancer Cell
(2007)
Paracrine Hedgehog signaling in stomach and intestine: new roles for hedgehog in gastrointestinal patterning
Gastroenterology
Wnt signaling during development of the gastrointestinal tract
Dev. Biol.
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
Cell
Downregulation of Hedgehog signaling is required for organogenesis of the small intestine in Xenopus
Dev. Biol.
Hedgehog signaling regulates expansion of pancreatic epithelial cells
Dev. Biol.
Hedgehog beyond medulloblastoma and basal cell carcinoma
Biochim. Biophys. Acta
Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID-beta2m−/− repopulating cells
Blood
Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos
Dev. Cell
Functional compensation in Hedgehog signaling during mouse prostate development
Dev. Biol.
Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines
J. Urol.
Mutations affecting segment number and polarity in Drosophila
Nature
The hedgehog signaling network
Am. J. Med. Genet. A
Communicating with Hedgehogs
Nat. Rev. Mol. Cell Biol.
Targeting the Hedgehog pathway in cancer
Nat. Rev. Drug Discov.
The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas
Nat. Genet.
Human homolog of patched, a candidate gene for the basal cell nevus syndrome
Science
Developmental genes and cancer: role of patched in basal cell carcinoma of the skin
J. Natl. Cancer Inst.
Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice
Oncogene
Activating Smoothened mutations in sporadic basal-cell carcinoma
Nature
Loss of suppressor-of-fused function promotes tumorigenesis
Oncogene
Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review
Neurosurgery
Mending and malignancy
Nature
A mouse model for medulloblastoma and basal cell nevus syndrome
J. Neurooncol.
Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice
Oncogene
High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice
Oncogene
Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors
Cancer Res.
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development
J. Pathol.
More than one way to skin
Genes Dev.
Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog
Nat. Med.
Basal cell carcinomas in mice overexpressing sonic hedgehog
Science
Sonic hedgehog signaling is essential for hair development
Curr. Biol.
Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog
J. Clin. Invest.
Basal cell carcinomas: attack of the hedgehog
Nat. Rev. Cancer
Metastasis from basal cell carcinoma
Va. Med.
Epidemiology and aetiology of basal cell carcinoma
Br. J. Dermatol.
Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice
Nat. Med.
Basal cell carcinomas in mice overexpressing Gli2 in skin
Nat. Genet.
Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
Proc. Natl. Acad. Sci. U. S. A.
Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta-catenin signaling
Nat. Genet.
Pharmacological treatments for basal cell carcinoma
Drugs
Cited by (180)
Exploring vismodegib: A non-surgical breakthrough in the management of advanced periocular basal cell carcinoma
2024, Cancer Treatment and Research CommunicationsSingle-molecule imaging in the primary cilium
2023, Methods in Cell BiologyExperimental and theoretical study of the structural features of Vismodegib molecule
2020, Journal of Molecular StructureCitation Excerpt :Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer with an estimated annual incidence of 0.1%–0.5% [1]. The inappropriate activation of the Hedgehog signaling pathway is associated with BCC [2]. For this reason, the US Food and Drug Administration (FDA) approved in 2012 the Vismodegib (GDC-0449) active principle (Erivedge®, Genentech).
Hh signaling from de novo organizers drive lgl neoplasia in Drosophila epithelium
2020, Developmental Biology